Why the study?
Literature on malignant cardiac tumors is relatively limited because they are rare, particularly among the Chinese population.
Does surgical treatment improve overall survival in patients with primary malignant cardiac tumors compared to non-surgical treatment?
Does surgical treatment improve overall survival in patients with primary malignant cardiac tumors compared to non-surgical treatment?
Answers are grounded in this paper and cite their sources.
Surgical treatment, particularly heart transplantation, significantly improves survival in patients with primary malignant cardiac tumors compared to non-surgical management.
The literature on malignant cardiac tumors is relatively limited because they are rare, especially among the Chinese population. We analyzed 14 patients diagnosed with malignant cardiac tumors in Fuwai Hospital and present the results of surgical treatments on the tumors. The mean age at tumor diagnosis was 47 years in a male-dominated cohort. There was a high frequency of pericardial effusion and coronary artery involvement in our group. We compared the survival times of patients who received different treatments and found that surgery improved prognosis of tumors, especially for patients who underwent orthotopic heart transplantation.
No takes yet. Share an insight, caveat, or question.
Guo et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: